Tilak Pathology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 0.50 M
as on 18-12-2024
- Company Age 22 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.24 M
as on 18-12-2024
- Revenue 4.75%
(FY 2021)
- Profit 23.33%
(FY 2021)
- Ebitda -283.23%
(FY 2021)
- Net Worth 3.23%
(FY 2021)
- Total Assets 3.26%
(FY 2021)
About Tilak Pathology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹0.24 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manglesh Srivastava and Savita Srivastava serve as directors at the Company.
- CIN/LLPIN
U85110UP2002PTC027141
- Company No.
027141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tilak Pathology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manglesh Srivastava  | Director | 23-Dec-2002 | Current |
| Savita Srivastava | Director | 23-Dec-2002 | Current |
Financial Performance of Tilak Pathology.
Tilak Pathology Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 4.75% increase. The company also saw a substantial improvement in profitability, with a 23.33% increase in profit. The company's net worth moved up by a moderate rise of 3.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tilak Pathology?
In 2017, Tilak Pathology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 03 Feb 2005 | ₹0.24 M | Satisfied |
How Many Employees Work at Tilak Pathology?
Unlock and access historical data on people associated with Tilak Pathology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tilak Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tilak Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
